Asia-Pacific Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia-Pacific Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 643 | Pages: 140 | October 2016 | Region: Asia Pacific


The Asia-Pacific Companion Diagnostics Market was worth USD 418.0 million in 2016 and estimated to be growing at a CAGR of 24.73%, to reach USD 1,507.1 million by 2022. Asia-Pacific ranks as the fastest growing market over the forecast period. Growth in the region is favoured by increasing population, increased spending on healthcare R&D by government and growing base of affluent middle class population.

Companion diagnostics are diagnostic tests used to increase effectiveness of the drug and for pre-determining the efficacy of the treatment. These products are mainly in-vitro devices or imaging tools, which are either developed after the drug is in the market or during drug development. Benefits provided by these products are providing crucial information on an individual’s risk factors for chronic conditions and enables health care professionals to decide whether drug it more beneficial over its risks or not.

Companion diagnostics have accompanied the development of personalized medicine, an advance approach in the clinical treatment process. Key factors driving the companion diagnostics market are accelerated drug regulatory approvals, merging new pharmaceuticals and diagnostics, improved efficacy profile of drugs and reduced healthcare expenditure. Complex clinical trial procedures are hindering the market growth.

The Asia-pacific clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the Asia-Pacific market is analysed under various regions namely, China, India, Japan, South Korea and Australia. Due to rapid increase in population in developing countries like China and India are the fastest growing markets in this region.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Companion Diagnostics Market By Region, From 2016-2022 (USD million)
  2. Asia-Pacific Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  3. Asia-Pacific Oncology Market By Region, From 2016-2022 (USD million)
  4. Asia-Pacific Inflammation and Autoimmune Diseases Market By Region, From 2016-2022 (USD million)
  5. Asia-Pacific Cardiovascular Diseases Market By Region, From 2016-2022 (USD million)
  6. Asia-Pacific Central Nervous System Disorders Market By Region, From 2016-2022 (USD million)
  7. Asia-Pacific Virology Diseases Market By Region, From 2016-2022 (USD million)
  8. Asia-Pacific Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  9. Asia-Pacific Immuno Histochemistry Market By Region, From 2016-2022 (USD million)
  10. Asia-Pacific Molecular Diagnostics Market By Region, From 2016-2022 (USD million)
  11. Asia-Pacific Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  12. Asia-Pacific Colorectal Cancer Diagnostics Market By Region, From 2016-2022 (USD million)
  13. Asia-Pacific Breast Cancer Diagnostics Market By Region, From 2016-2022 (USD million)
  14. Asia-Pacific Lung Cancer Diagnostics Market By Region, From 2016-2022 (USD million)
  15. Asia-Pacific Gastric Cancer Diagnostics Market By Region, From 2016-2022 (USD million)
  16. Asia-Pacific Melanoma Diagnostics Market By Region, From 2016-2022 (USD million)
  17. Asia-Pacific Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
  18. Asia-Pacific In-Situ Hybridization Market By Region, From 2016-2022 (USD million)
  19. Asia-Pacific Real Time PCR Market By Region, From 2016-2022 (USD million)
  20. Asia-Pacific Gene Sequencing Market By Region, From 2016-2022 (USD million)
  21. China Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  22. China Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  23. China Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  24. China Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
  25. India Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  26. India Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  27. India Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  28. India Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
  29. Japan Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  30. Japan Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  31. Japan Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  32. Japan Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
  33. South Korea Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  34. South Korea Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  35. South Korea Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  36. South Korea Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
  37. Australia Companion Diagnostics Market By Indication, From 2016-2022 (USD million)
  38. Australia Companion Diagnostics Market By Technology, From 2016-2022 (USD million)
  39. Australia Oncology Diagnostics Market By Type, From 2016-2022 (USD million)
  40. Australia Molecular Diagnostics Market By Type, From 2016-2022 (USD million)
Middle East And Africa Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU,...
Latin America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Asia Pacific Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Th...
Europe Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermogr...
North America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, O...
Middle East And Africa High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (T...
Latin America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
Asia Pacific High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Iden...
Europe High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identifica...
North America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identification, P...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.